PortfoliosLab logoPortfoliosLab logo
CDTX vs. COGT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CDTX vs. COGT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cidara Therapeutics, Inc. (CDTX) and Cogent Biosciences, Inc. (COGT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


CDTX

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

COGT

1D
-1.53%
1M
-12.17%
YTD
-9.18%
6M
-17.62%
1Y
457.17%
3Y*
35.49%
5Y*
32.16%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CDTX vs. COGT - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
CDTX
Cidara Therapeutics, Inc.
0.22%721.76%69.27%4.98%-40.45%-36.50%-47.92%63.40%-41.25%
COGT
Cogent Biosciences, Inc.
-9.18%355.38%32.65%-49.13%34.73%-23.60%289.93%-83.64%-60.40%

Correlation

The correlation between CDTX and COGT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Apr 2, 2018

0.18

Fundamentals

Market Cap

CDTX:

$3.44B

COGT:

$2.17B

EPS

CDTX:

-$11.88

COGT:

-$3.89

PB Ratio

CDTX:

8.15

COGT:

3.76

Total Revenue (TTM)

CDTX:

$0.00

COGT:

$0.00

Gross Profit (TTM)

CDTX:

-$45.00M

COGT:

-$2.33M

EBITDA (TTM)

CDTX:

-$189.91M

COGT:

-$363.18M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CDTX vs. COGT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CDTX

COGT
COGT Risk / Return Rank: 9898
Overall Rank
COGT Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
COGT Sortino Ratio Rank: 9999
Sortino Ratio Rank
COGT Omega Ratio Rank: 9898
Omega Ratio Rank
COGT Calmar Ratio Rank: 9999
Calmar Ratio Rank
COGT Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDTX vs. COGT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cidara Therapeutics, Inc. (CDTX) and Cogent Biosciences, Inc. (COGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

CDTX vs. COGT - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


CDTXCOGTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.53

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.02

Drawdowns

CDTX vs. COGT - Drawdown Comparison


Loading charts...

Drawdown Indicators


CDTXCOGTDifference

Max Drawdown

Largest peak-to-trough decline

-98.09%

Max Drawdown (1Y)

Largest decline over 1 year

-25.79%

Max Drawdown (3Y)

Largest decline over 3 years

-69.87%

Max Drawdown (5Y)

Largest decline over 5 years

-76.34%

Current Drawdown

Current decline from peak

-51.91%

Average Drawdown

Average peak-to-trough decline

-77.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.29%

Volatility

CDTX vs. COGT - Volatility Comparison


Loading charts...

Volatility by Period


CDTXCOGTDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.42%

Volatility (6M)

Calculated over the trailing 6-month period

31.76%

Volatility (1Y)

Calculated over the trailing 1-year period

130.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

95.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

166.35%

Dividends

CDTX vs. COGT - Dividend Comparison

Neither CDTX nor COGT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CDTX vs. COGT - Financials Comparison

This section allows you to compare key financial metrics between Cidara Therapeutics, Inc. and Cogent Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M2022202320242025202600
(CDTX) Total Revenue
(COGT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CDTX and COGT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CDTX and COGT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer